SME Times is powered by   
Search News
Just in:   • Adani Group to invest Rs 57,575 crore in Odisha  • 'Dollar Distancing' finally happening? Time for India to pitch Rupee as credible alternative: SBI Ecowrap  • 49% Indian startups now from tier 2, 3 cities: Jitendra Singh  • 'India ranks 3rd in global startup ecosystem & number of unicorns'  • LinkedIn lays off entire global events marketing team: Report 
Last updated: 27 Sep, 2014  

Asia-Pacific Solid Tumors Market Size, Share, Forecast, Analysis

PR Newswire | 23 Sep, 2013
ALBANY, New York: Researchmoz.us added New Market Research Report which included in Pharmaceutical Market Research Reports & Industry Analysis - Title of that Report "Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies (http://www.researchmoz.us/solid-tumors-market-in-asia-pacific-to-2019-new-drug-approvals-and-anticipated-product-launches-to-trigger-a-shift-in-treatment-paradigm-to-targeted-therapies-report.html)" to its vast database.

The leading business intelligence provider, has released its latest research: Solid Tumors in Asia-Pacific Market to 2019 - New and Anticipated Approvals of Targeted Therapies to Trigger a Shift in Treatment Paradigm, which provides in-depth analysis of four key therapeutic indications within the Asia-Pacific (APAC) solid tumors market - bladder cancer, ovarian cancer, pancreatic cancer and prostate cancer - covering the four countries of Australia, China, India and Japan. The report provides an estimation of market size for 2012, along with market forecast until 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis for these four solid tumor types.

The value of the solid tumors market in the APAC region amounted to an estimated $1 billion in 2012 and is expected to register a modest Compound Annual Growth Rate (CAGR) of 12.3% to reach $2.3 billion in 2019. The key drivers for growth in this market include: new product approvals in ovarian, pancreatic and prostate cancers; expected launches from the promising ovarian and prostate cancer pipelines; and increased market penetration due to the anticipated implementation of social insurance in China. Conversely, the growth of the market in this region could face some restricting influences, including: the recent implementation of a price ceiling on essential drugs in India; anticipated pricing restrictions in China; low access and penetration; and price erosion due to generic competition.

Scope

The report analyzes treatment usage patterns, market characterization, pipeline analysis and key licensing and co-development deals in the bladder cancer, ovarian cancer, pancreatic cancer and prostate cancer in the four APAC markets of Australia, China, India and Japan.

The report includes:

Disease overview, as well as treatment algorithms and treatment usage patterns

Market size and forecast for the APAC solid tumors market from 2012 to 2019

Major marketed products in the APAC region for all four solid tumor types covered

In-depth pipeline analysis for all four solid tumor types

Key drivers and restraints that have had and are expected to have a significant impact upon the market

Key licensing and co-development agreements in the solid tumors market

Reasons to Buy

The report will enhance your decision-making capability by allowing you to:

Align your product portfolio to the markets with high growth potential

Develop market entry and expansion strategies by identifying the potential regions and therapeutic segments poised for strong growth

Devise a more effectively tailored country strategy through the understanding of key drivers and barriers in the solid tumors market

Develop key strategic initiatives based upon an understanding of key focus areas and leading companies

Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships

TABLE OF CONTENT
1.1 List of Tables
1.2 List of Figures

2 Solid Tumors Market in Asia Pacific to 2019 - Introduction
2.1 Introduction

3 Solid Tumors Market in Asia Pacific to 2019 - Therapeutic Landscape
3.1 Bladder Cancer
3.1.1 Symptoms
3.1.2 Etiology
3.1.3 Pathophysiology
3.1.4 Diagnosis
3.1.5 Classification
3.1.6 Epidemiology
3.1.7 Prognosis and Disease Staging
3.1.8 Treatment Options
3.2 Ovarian Cancer
3.2.1 Symptoms
3.2.2 Etiology
3.2.3 Pathophysiology
3.2.4 Diagnosis
3.2.5 Classification
3.2.6 Epidemiology
3.2.7 Prognosis and Disease Staging
3.2.8 Treatment Options
3.3 Pancreatic Cancer
3.3.1 Symptoms
3.3.2 Etiology
3.3.3 Pathophysiology
3.3.4 Diagnosis
3.3.5 Classification
3.3.6 Epidemiology
3.3.7 Prognosis and Disease Staging
3.3.8 Treatment Algorithm
3.4 Prostate Cancer
3.4.1 Symptoms
3.4.2 Etiology
3.4.3 Pathophysiology
3.4.4 Co-Morbidities and Complications
3.4.5 Diagnosis
3.4.6 Classification
3.4.7 Epidemiology
3.4.8 Prognosis and Disease Staging
3.4.9 Treatment Options

4 Solid Tumors Market in Asia Pacific to 2019 - Marketed Products
4.1 Bladder Cancer
4.2 Ovarian Cancer
4.3 Pancreatic Cancer
4.4 Prostate Cancer
4.5 Key Marketed Products
4.5.1 Carboplatin
4.5.2 Cisplatin
4.5.3 Gemcitabine
4.5.4 Paclitaxel
4.5.5 Doxorubicin
4.5.6 Avastin (bevacizumab)
4.5.7 Tarceva (erlotinib)
4.5.8 Sutent (sunitinib)
4.5.9 Afinitor (everolimus)
4.5.10 Taxotere (docetaxel)
4.5.11 Zytiga (abiraterone acetate)
4.5.12 Jevtana (cabazitaxel)

5 Solid Tumors Market in Asia Pacific to 2019 - Pipeline Analysis
5.1 Bladder Cancer Pipeline
5.1.1 Overall Pipeline
5.1.2 Pipeline Analysis by Molecule Type
5.1.3 Pipeline Analysis by Mechanism of Action
5.2 Ovarian Cancer Pipeline
5.2.1 Overall Pipeline
5.2.2 Pipeline Analysis by Molecule Type
5.2.3 Pipeline Analysis by Mechanism of Action
5.3 Pancreatic Cancer Pipeline
5.3.1 Overall Pipeline
5.3.2 Pipeline Analysis by Molecule Type
5.3.3 Pipeline Analysis by Mechanism of Action
5.4 Prostate Cancer Pipeline
5.4.1 Overall Pipeline
5.4.2 Pipeline Analysis by Molecule Type
5.4.3 Pipeline Analysis by Mechanism of Action
5.5 Promising Drug Candidates in the Pipeline
5.5.1 Abraxane (albumin-bound paclitaxel)
5.5.2 AMG 386 (trebananib)
5.5.3 Votrient (pazopanib)
5.5.4 Xtandi (enzalutamide)

6 Solid Tumors Market in Asia Pacific to 2019 - Market Forecast
6.1 Asia-Pacific Market
6.1.1 Treatment Usage Patterns
6.1.2 Annual Cost of Treatment
6.1.3 Market Size
6.2 India
6.2.1 Treatment Usage Patterns
6.2.2 Annual Cost of Treatment
6.2.3 Market Size
6.3 Australia
6.3.1 Treatment Usage Patterns
6.3.2 Annual Cost of Treatment
6.3.3 Market Size
6.4 China
6.4.1 Treatment Usage Patterns
6.4.2 Annual Cost of Treatment
6.4.3 Market Size
6.5 Japan
6.5.1 Treatment Usage Patterns
6.5.2 Annual Cost of Treatment
6.5.3 Market Size
6.6 Drivers and Barriers for the Solid Tumors Market in APAC
6.6.1 Drivers
6.6.2 Barriers

7 Solid Tumors Market in Asia Pacific to 2019 - Deals and Strategic Consolidations
7.1 Deals Analysis
7.2 Major Co-Development Deals
7.2.1 ScinoPharm Taiwan and Coland Enter into Agreement to Develop Generic Oncological Drugs
7.2.2 Bind Biosciences Enters into Agreement with Amgen to Develop Cancer Drugs
7.2.3 Merck Enters into Co-Development Agreement with Endocyte for Cancer Drug
7.2.4 Merck Serono Enters into Co-Development Agreement with Threshold Pharma for TH-302,
Pancreatic Cancer Drug
7.2.5 Seattle Genetics Exercises Option for Co-Development Agreement with Agensys (affiliate of
Astellas) for ASG-15ME
7.3 Major Licensing Deals
7.3.1 Spectrum Pharma Amends Licensing Agreement with Allergan for Apaziquone
7.3.2 Chugai Pharma Enters Into Licensing Agreement with Debiopharm Group for FF284
7.3.3 Baxter International Enters into Licensing Agreement with Onconova Therapeutics for
Rigosertib
7.3.4 Dyax Enters Into Licensing Agreement with Kadmon for Oncology Drug
7.3.5 Medigene Extends Licensing Agreement with Syncore for EndoTAG-1

8 Solid Tumors Market in Asia Pacific to 2019 - Appendix
8.1 Pipeline Drugs by Phase
8.1.1 Phase III
8.1.2 Pre-registration/NDA-filed
8.2 Market Forecasts to 2018
8.2.1 APAC
8.2.2 Australia
8.2.3 China
8.2.4 India
8.2.5 Japan
8.3 Market Definitions
8.4 Abbreviations
8.5 Sources
8.6 Research Methodology
8.6.1 Coverage
8.6.2 Secondary Research
8.6.3 Primary Research
8.6.4 Therapeutic Landscape
8.6.5 Geographical Landscape
8.6.6 Pipeline Analysis
8.7 Expert Panel Validation
8.8 Contact Us
8.9 Disclaimer

Related Reports:

Business Intelligence & Analytics Market in India 2013:The Business Intelligence & Analytics Market in India is part of Netscribes' IT & ITeS Series reports. Advent of smartphones and tablets along with rising adoption in key sectors such as BFSI, Healthcare, Retail etc. will have a favorable impact on the Indian Business Intelligence & Analytics Market. The report begins with an overview of the major macroeconomic indicators which highlights the present economic scenario prevalent in India. It is followed by an introduction section which provides a typical architectural model of Business Intelligence (BI). It also shows the value proposition by BI & Analytics. It further describes types of Business Intelligence available in the market. The market overview section provides a brief snapshot of the BI & Analytics market in India. It shows the market size and growth of the market in India. Further it shows segmentation of the market by SMBs and non-SMBs in 2012. It also provides industry vertical wise split of BI usage in the country. This section further highlights the market leads in BI & Analytics market in India. Browse Complete Report with TOC @ http://www.researchmoz.us/business-intelligence-and-analytics-market-in-india-2013-report.html

Global SMB Web Analytics Market 2012-2016: Analysts forecast the Global SMB Web Analytics market to grow at a CAGR of 16.9 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need to enhance marketing activities. The Global SMB Web Analytics market has also been witnessing the increasing demand for mobile analytics. However, the lack of skilled personnel could pose a challenge to the growth of this market. The Global SMB Web Analytics Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global SMB Web Analytics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Browse Complete Report with TOC @ http://www.researchmoz.us/global-smb-web-analytics-market-2012-2016-report.html

Global Advanced Analytics Market 2012-2016: Analysts forecast the Global Advanced Analytics market to grow at a CAGR of 13.62 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growth of predictive analytics. The Global Advanced Analytics market has also been witnessing the emergence of advanced analytics in social gaming. However, the lack of expertise could pose a challenge to the growth of this market. The Global Advanced Analytics Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the EMEA and APAC regions; it also covers the Global Advanced Analytics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Browse Complete Report With TOC @ http://www.researchmoz.us/global-advanced-analytics-market-2012-2016-report.html

Advanced Analytics in the Social Gaming Industry 2012: Advanced gaming analytics help social gaming companies improve their understanding of game-related data and use this understanding to gain insights into consumer behavior. These insights also help companies deal with a varied range of areas that have significant potential to enhance gaming success. They also provide companies with a better understanding about why users quit a certain game, and help them find other players that are likely to abandon the game. Using these insights, gaming companies can develop retention strategies before players quit their game, and this in turn optimizes ad-generated interaction and in-game virtual goods sales. TechNavio's analysts expect the Advanced Analytics segment in the Social Gaming industry to grow rapidly over the period 2012-2016. The growth of the Advanced Analytics segment is driven by many factors. One of the major drivers is the need for enterprises to optimize consumer relationships. Advanced analytics provides an insight into the purchasing-related demand for various products. This insight is then used by marketers to formulate marketing strategies for greater sales visibility of their products and also to encourage increased consumer satisfaction. Browse Complete Report With TOC @ http://www.researchmoz.us/advanced-analytics-in-the-social-gaming-industry-2012-report.html

Browse Complete Report with TOC @ http://www.researchmoz.us/solid-tumors-market-in-asia-pacific-to-2019-new-drug-approvals-and-anticipated-product-launches-to-trigger-a-shift-in-treatment-paradigm-to-targeted-therapies-report.html

About Us

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Contact
M/s. Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-997-4948

Email: sales@researchmoz.com
http://www.researchmoz.us/
http://www.researchmoz.blogspot.com/

 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
66.20
64.50
UK Pound
87.50
84.65
Euro
78.25
75.65
Japanese Yen 58.85 56.85
As on 13 Aug, 2022
  Daily Poll
PM Modi's recent US visit to redefine India-US bilateral relations
 Yes
 No
 Can't say
  Commented Stories
» GIC Re's revenue from obligatory cession threatened(1)
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter